Market open
Iterum Therapeutics plc/$ITRM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Ticker
$ITRM
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Dublin, Ireland
Employees
9
ISIN
IE000TTOOBX0
Website
ITRM Metrics
BasicAdvanced
$36M
-
-$1.26
2.27
-
Price and volume
Market cap
$36M
Beta
2.27
52-week high
$1.50
52-week low
$0.88
Average daily volume
464K
Financial strength
Current ratio
1.408
Quick ratio
1.374
Long term debt to equity
-761.358
Total debt to equity
-1,117.398
Interest coverage (TTM)
-7.41%
Management effectiveness
Return on assets (TTM)
-32.98%
Return on equity (TTM)
472.61%
Valuation
Price to book
-8.11
Price to tangible book (TTM)
-1.39
Price to free cash flow (TTM)
-0.773
Growth
Earnings per share change (TTM)
-57.44%
3-year earnings per share growth (CAGR)
-46.88%
ITRM News
AllArticlesVideos
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewsWire·3 days ago
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
GlobeNewsWire·1 week ago
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Iterum Therapeutics plc stock?
Iterum Therapeutics plc (ITRM) has a market cap of $36M as of May 09, 2025.
What is the P/E ratio for Iterum Therapeutics plc stock?
The price to earnings (P/E) ratio for Iterum Therapeutics plc (ITRM) stock is 0 as of May 09, 2025.
Does Iterum Therapeutics plc stock pay dividends?
No, Iterum Therapeutics plc (ITRM) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Iterum Therapeutics plc dividend payment date?
Iterum Therapeutics plc (ITRM) stock does not pay dividends to its shareholders.
What is the beta indicator for Iterum Therapeutics plc?
Iterum Therapeutics plc (ITRM) has a beta rating of 2.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.